Replies to post #387602 on Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

STI’s research is bogus too, 100-500 FTE’s, 100-500M annual rev? This is taking a shot in the dark. They might have some minor insights, but they are completely guessing where it wouldn’t be reliable.

I’m not sure how much of Takeda’s Adderall ER rev was from US business vs other geographies. Don’t think any CNS stimulants are permitted in Japan so rev would be from other geographies.

Prasco/Burel Adderall ER launch would be for fiscal Q4 to add some nice revenue growth for the year.

How does DEA allocate API for this? Not sure Don’t think simply takes over Takeda’s quota.

[HGilS]

Hi. Great post.

I would like to add that Prasco has a huge basket of products. And they think “business”. They looked at Elite, the quality of its adderall, the team in place, honest people, family people, who respect human beings and who are in business to help people - not to abuse them like Purdue.

Think what potential elite has to manufacture more and more Prasco products. Prasco buy anda’s and sell products. They found in elite a potential manufacturer they could buy if there is a click.

By the way very similar profile as dexcel. Buyout war?